Multidisciplinary Care for Patients with Cardiac Amyloidosis: a Lesson from the 2023 American College of Cardiology Expert Consensus

Abstract

Amyloidosis is a rare and varied group of diseases defined by the misfolding, aggregation, and deposition of highly structured fibrils made of low molecular weight protein subunits known as amyloid deposits throughout different tissues. Depending on their form and location, amyloid deposits can produce a variety of clinical manifestations resulting in considerable morbidity, death, and a deterioration in quality of life. "Cardiac amyloidosis" refers to the clinical condition associated with cardiac amyloid infiltration of the heart. The American College of Cardiology has issued an expert consensus addressing cardiological management of cardiac amyloidosis, the need for an interdisciplinary approach to extra-cardiac manifestations and highlighting the importance of removing barriers to equitable care for patients with amyloidosis. In this editorial we summarize and discuss on relevant issues addressed in the consensus.